FDA.reportPublic FDA data

fruquintinib 5 MG Oral Capsule [Fruzaqla]

RxCUI
2670198
RxNorm name
fruquintinib 5 MG Oral Capsule [Fruzaqla]
Display name
fruquintinib 5 MG Oral Capsule [Fruzaqla]
Full name
fruquintinib 5 MG Oral Capsule [Fruzaqla]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FruzaqlaFRUQUINTINIBTakeda Pharmaceuticals America, Inc.186d786e-dc8a-45f2-b5e1-01ac0201879f2026-07-31Warnings, Adverse reactionsExact identifier
rxcui: 2670198

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
186d786e-dc8a-45f2-b5e1-01ac0201879fFruzaqla 5 MG Oral Capsule [PSN] · fruquintinib 5 MG Oral Capsule [Fruzaqla] [SBD] · Fruzaqla 5 MG Oral Capsule [SY]36These highlights do not include all the information needed to use FRUZAQLA safely and effectively. See full prescribing information for FRUZAQLA. FRUZAQLA ® (fruquintinib) capsules, for oral use Initial U.S. Approval: 202320260205